The cancer drug world will focus on Chicago at this weekend’s American Society of Clinical Oncology meeting.
As I reported in last week’s print edition, this opportunity to report data from recent studies is a make-or-break meeting for many drug developers. It’s a chance to hook up with potential clinicians, investors and partners.
Here is a quick look at what some Bay Area companies are showcasing at ASCO.
No comments:
Post a Comment